Looking to publish in Human Vaccines & Immunotherapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginHuman Vaccines & Immunotherapeutics is an international open access peer-reviewed journal focused on human vaccinology and immunotherapy. It publishes research on novel vaccines and immunotherapeutics, preclinical studies, clinical trials, disease mechanisms, licensed products, vaccine acceptance and hesitancy, policy, safety, surveillance, epidemiology, pharmaco-economics, and related public health topics. The journal operates single-anonymized peer review, is affiliated with the International Society for Vaccines and the Association for Cancer Immunotherapy, and has been fully open access since Volume 18 in 2022.
Looking to publish in Human Vaccines & Immunotherapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Human Vaccines & Immunotherapeutics accepts the following article types. Click on an article type to view submission instructions.
Research Articles
Review Article
State-Of-The-Art Reviews
Case Report
Rapid Communication
Mini-Reviews
Recent Publications
Cost-effectiveness of finotonlimab plus bevacizumab versus sorafenib as first-line therapy in unresectable hepatocellular carcinoma in China
Huihui Xu, Shengjian Yu, Yan Yang, Haoze Bian, Zimiao Wu, Feng Xuan
Prevention is better than cure: Awareness and acceptance of the HPV vaccine for condyloma acuminata (CA) among college students who self-report no sexual experience
Qingjing Shao, Min Peng, Xuechun Lin, Yuying Zheng, Yutang Feng, Wujian Ke, Huachun Zou, Xuqi Ren
Passive surveillance of adverse events following immunization for National Immunization Program vaccines in Shenyang, China, 2009–2024
Nina Jia, Wei Zhong, Dongmei Gao, Lijun Zhu, Xuanyi Li
Factors influencing vaccine uptake during pregnancy: A systematic literature review
Dasha Shamarina, Lina María Cortes Rueda, David Alderson, Anne T. Collins
Lessons learned from the deployment of oral cholera vaccine by maintaining the controlled temperature chain (CTC) in an urban setting, Bangladesh
Md. Taufiqul Islam, Ashraful Islam Khan, Zahid Hasan Khan, Mohammad Ashraful Amin, Sabina Shahnaz, Quazi Fayeza Sultana, Md. Taufiqur Rahman Bhuiyan, Abhishek Rimal, Joanie Robertson, Anna-Lea Kahn, Firdausi Qadri
Frequently asked questions
How long does it take to publish?
25 days average from submission to first decision; 48 days average from submission to first post-review decision; 14 days average from acceptance to online publication.
Reformat to Human Vaccines & Immunotherapeutics using Livewrite PremiumIs a cover letter required?
A cover letter is not used for APC waiver requests. Waiver requests must be made at the time of online submission, not in a cover letter.
Reformat to Human Vaccines & Immunotherapeutics using Livewrite PremiumWhat are the publication costs?
Open access costs may be covered by a Taylor & Francis open access agreement; journal-specific charges vary.
Reformat to Human Vaccines & Immunotherapeutics using Livewrite Premium